As of January 22, 2025, Arcturus Therapeutics (ARCT) has a market cap of $0.45 billion USD. According to our data, Arcturus Therapeutics is ranked No.6240 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.45 B |
-1.36%
|
Dec 31, 2024 | $0.46 B |
-46.18%
|
Dec 29, 2023 | $0.85 B |
85.91%
|
Dec 30, 2022 | $0.46 B |
-54.17%
|
Dec 31, 2021 | $1.00 B |
-14.68%
|
Dec 31, 2020 | $1.18 B |
299.08%
|
Dec 31, 2019 | $0.29 B |
139.96%
|
Dec 31, 2018 | $0.12 B |
-43.02%
|
Dec 29, 2017 | $0.22 B |
-45.92%
|
Dec 30, 2016 | $0.40 B |
-66.56%
|
Dec 31, 2015 | $1.19 B |
68.36%
|
Dec 31, 2014 | $0.71 B |
-79.28%
|
Dec 31, 2013 | $3.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Arrowhead Pharmaceuticals
ARWR
|
$2.45 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Market Cap | = | ARCT Stock Price | * | ARCT Shares Outstanding |
= | $16.74 | * | 27.09 M | |
= | $0.45 B |